If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

Share Price is delayed by 15 minutes
Get Live Data
31.60    -0.20 (-0.63%)
Bid:
31.62
Ask:
31.82
Spread: 0.20 (0.633%)
Market Cap: £501.45m
THG Live PriceLast checked at - London Stock Exchange

Intraday Thg Share Chart

Result of AGM

24 Jun 2026 14:45

RNS Number : 6241J
THG PLC
24 June 2026
 

THG PLC

(the "Company")

24 June 2026

Results of Annual General Meeting

Following its annual general meeting ("AGM" or "Meeting") which was held today at 1:00 p.m., the Company is pleased to announce that all resolutions which were put to the Meeting were duly passed by the requisite majorities. Resolutions 1 to 15 were passed by the shareholders of the Company as ordinary resolutions, and resolutions 16 to 21 were passed as special resolutions. All resolutions were voted on by poll.

Total votes received for each ordinary resolution and special resolution proposed at the AGM were as follows:

Resolution

*Votes for

%age of votes cast

Votes against

%age of votes cast

Total votes cast

**%age of ISC voted

***Votes withheld

1. To receive the Report & Accounts

1,140,236,715

98.90%

12,721,036

1.10%

1,152,957,751

70.29

1,211,675

2. To approve the Directors' Remuneration Report (excluding the Directors' Remuneration Policy)

1,108,280,025

96.09%

45,042,526

3.91%

1,153,322,551

70.31

846,875

3. To re-elect Charles Allen, Lord Allen of Kensington CBE, as a Director

990,532,733

87.29%

144,169,528

12.71%

1,134,702,261

69.17

19,467,165

4. To re-elect Sue Farr as a Director

1,108,859,161

96.21%

43,659,612

3.79%

1,152,518,773

70.26

1,650,653

5. To re-elect Helen Jones as a Director

1,092,583,517

96.39%

40,918,261

3.61%

1,133,501,778

69.10

20,667,648

6. To re-elect Gillian Kent as a Director

1,109,460,089

96.27%

43,014,711

3.73%

1,152,474,800

70.26

1,694,626

7. To re-elect Edward Koopman as a Director

1,108,907,320

96.22%

43,567,480

3.78%

1,152,474,800

70.26

1,694,626

8. To re-elect Dean Moore as a Director

1,109,729,238

96.29%

42,745,562

3.71%

1,152,474,800

70.26

1,694,626

9. To re-elect Matthew Moulding as a Director

1,105,129,979

95.78%

48,688,354

4.22%

1,153,818,333

70.34

351,093

10.  To re-elect Milyae Park as a Director

1,111,715,733

96.46%

40,761,157

3.54%

1,152,476,890

70.26

1,692,536

11.  To re-elect Damian Sanders as a Director

1,107,877,805

96.10%

44,942,715

3.90%

1,152,820,520

70.28

1,348,906

12.  To re-appoint Ernst & Young LLP as auditor

1,133,460,912

98.31%

19,483,157

1.69%

1,152,944,069

70.28

1,225,357

13.  To authorise the Audit Committee to determine the auditor's remuneration

1,133,535,532

98.41%

18,260,903

1.59%

1,151,796,435

70.21

2,372,991

14.  To authorise the Directors to allot shares

1,105,178,321

95.81%

48,317,307

4.19%

1,153,495,628

70.32

673,798

15.  To authorise political donations

944,078,076

96.33%

36,008,194

3.67%

980,086,270

59.75

174,083,156

16.  To authorise the Directors to disapply statutory pre-emption rights

1,101,211,206

95.52%

51,681,564

4.48%

1,152,892,770

70.28

1,276,656

17.  To authorise the Directors to further disapply statutory pre-emption rights in connection with an acquisition or specified capital investment

1,105,109,539

95.85%

47,790,280

4.15%

1,152,899,819

70.28

1,269,607

18.  To authorise the Company to purchase its own shares

1,124,702,320

97.52%

28,631,758

2.48%

1,153,334,078

70.31

835,348

19.  To authorise a 14-day notice period for general meetings other than annual general meetings

1,040,480,211

90.23%

112,663,035

9.77%

1,153,143,246

70.30

1,026,180

20.  To authorise the cancellation of the Company's share premium account and capital redemption reserve

1,117,840,747

97.09%

33,480,481

2.91%

1,151,321,228

70.19

2,848,198

21.  To authorise the appropriation of the Company's profits (to be treated as distributable profits) to payment of the Ingenuity Distribution and authorise entry into the Electing Shareholders' Deed of Release and the Directors' Deed of Release

945,865,787

95.30%

46,632,097

4.70%

992,497,884

60.50

5,115,406

\* The votes of any proxy giving the Chair discretion as to how to vote have been included in the votes "For" a resolution.

*\* The total number of ordinary shares in issue (excluding treasury shares) and eligible to be voted at the AGM was 1,640,392,742.

***A vote withheld is not a vote in law and is not counted in the calculation of percentage of votes "For" or "Against" a resolution.

In accordance with UKLR 6.4.2R and 6.4.3R, a copy of all resolutions, other than resolutions concerning ordinary business, will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. A copy of the poll results for the AGM will also be available shortly on the Company's website at https://www.thg.com/investor-relations/annual-general-meeting-documents.

 

If you require further information, please contact:

James PochinGeneral Counsel & Company Secretary THG PLC Telephone No.: 020 7250 1446

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFIMJTMTJTBRF
Date   Source Headline
24th Jun 20262:45 pmRNSResult of AGM
24th Jun 20267:00 amRNSAGM Trading Statement
12th Jun 20267:00 amRNS-R€445m Term Loan B trading above par at record high
22nd May 20267:00 amRNSNotice of AGM
21st Apr 20267:00 amRNSTrading Statement
20th Apr 20264:45 pmRNSNotice of Q1 Trading Update
8th Apr 20267:00 amRNSAnnual Report & Accounts 2025
26th Mar 20267:00 amRNSPreliminary FY 2025 results
25th Mar 20264:54 pmRNSNotice of Results
24th Feb 20267:45 amRNSPDMR/PCA Shareholding & TR-1 Notification
12th Feb 20267:00 amRNS-RMyprotein licensing partnership with Greencore
2nd Feb 20267:00 amRNSTotal Voting Rights
27th Jan 20263:49 pmRNSTR-1: Notification of major holdings
27th Jan 20263:45 pmRNSTR-1: Notification of Major Holdings
23rd Jan 20262:52 pmRNSTR-1: Notification of Major Holdings
22nd Jan 20263:00 pmRNSApplication for Listing and Total Voting Rights
16th Jan 20267:00 amRNSChange to Board Committee Membership
13th Jan 20267:00 amRNSQ4 2025 Trading Statement
12th Jan 20264:40 pmRNSNotice of Results
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
16th Dec 20255:50 pmRNSTR-1: Notification of Major Holdings
9th Dec 20254:35 pmRNSTR-1: Notification of Major Holdings
9th Dec 202510:55 amRNSTR-1: Notification of Major Holdings
9th Dec 20259:15 amRNSPDMR/PCA Shareholding & TR-1 Notification
5th Dec 202510:15 amRNSDirector Declaration
5th Dec 202510:05 amRNSAdmission of Convertible Loan Shares and TVR
26th Nov 20259:45 amRNSPDMR/PCA Shareholdings
17th Nov 20257:00 amRNS-RMyprotein joins forces with Mars
3rd Nov 20257:00 amRNSBlock listing Interim Review
28th Oct 202511:14 amRNSDirector Declaration
14th Oct 20257:00 amRNSQ3 2025 Trading Statement
10th Oct 20257:00 amRNSNotice of Trading Update
19th Sep 20256:00 pmRNSOcean Wilsons
11th Sep 20257:00 amRNSInterim results for half-year ended 30 June 2025
10th Sep 20254:45 pmRNSNotice of Interim Results
5th Sep 20257:00 amRNSNotification under UKLR 6.4.9R(2)
6th Aug 20257:42 amRNSDisposal, H1 trading and Nutrition update - Amend
6th Aug 20257:00 amRNSDisposal, H1 trading and Nutrition update
9th Jul 20252:24 pmRNSChanges to Directors’ Responsibilities
25th Jun 20252:38 pmRNSResult of AGM
25th Jun 20257:00 amRNSAGM Trading Statement
5th Jun 20253:56 pmRNSTR-1: Notification of Major Holdings
23rd May 20257:00 amRNSNotice of AGM
1st May 20257:00 amRNSBlock Listing Six Monthly Return
30th Apr 20257:00 amRNSAnnual Report & Accounts 2024
29th Apr 20257:00 amRNSFY 2024 results and Q1 trading statement
23rd Apr 20257:00 amRNSResponse to media speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.